Prostaglandins and hypertension in chronic renal diseases. 1975

A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez

The role of prostaglandin A (PG A) in the pathogenesis of renal hypertension has been studied. The concentration of endogenous PG A was measured in the peripheral plasma by radioimmunoassay in patients with chronic renal disease and in control subjects. The mean plasma concentration of PG A1 equivalents was as follows: 1. normotensive healthy volunteers (n=23): 115 +/- 15 pg/ml 2. patients in terminal renal failure on regular hemodialysis a) anephric patients (n=6): 51+/- 21 pg/ml b) patients retaining their own kidneys, all but one with hypertension (n=9): 231 +/- 51 pg/ml (P less than 0.01 versus control) 3. patients with chronic renal disease a) with hypertension (n=7): 204 +/- 60 pg/ml (P less than 0.01 versus control) b) without hypertension (n=11): 136 +/- 30 pg/ml. Renal hypertension was associated with high levels of PG A in peripheral blood. This increase is probably a secondary adaptative mechanism for the excretion of a greater fraction of the glomerular filtrate at a lower blood pressure. PG A may represent a circulating "antihypertensive hormones".

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011454 Prostaglandins A (13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid (PGA(1)); (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid (PGA(2)); (5Z,13E,15S,17Z)-15-hydroxy-9-oxoprosta-5,10,13,17-tetraen-1-oic acid (PGA(3)). A group of naturally occurring secondary prostaglandins derived from PGE; PGA(1) and PGA(2) as well as their 19-hydroxy derivatives are found in many organs and tissues. PGA
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic

Related Publications

A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
January 1986, Scandinavian journal of gastroenterology,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
March 1986, Kardiologiia,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
September 1973, The Medical annals of the District of Columbia,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
January 1978, Contributions to nephrology,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
February 1983, Medicina clinica,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
June 1976, Archives of internal medicine,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
May 1969, Annals of internal medicine,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
January 1995, Vestnik Rossiiskoi akademii meditsinskikh nauk,
A Hornych, and J Bedrossian, and J Bariety, and J Menard, and P Corvol, and M Safar, and F Fontaliran, and P Milliez
May 1982, Prostaglandins, leukotrienes, and medicine,
Copied contents to your clipboard!